B4GALT5 and obesity disorder: Downregulation of B4GalT5 expression in subcutaneous adipose tissue alleviated insulin resistance, inflammation, and improved metabolic status of high-fat diet (HFD)-induced obesity and ob/ob mice by promoting adipogenic commitment and reducing macrophage inflammation in adipose tissue.